I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Eicosapentaenoic
Acid by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Eicosapentaenoic Acid by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Eicosapentaenoic Acid by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Dietary
Supplements & Functional Foods by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Dietary Supplements &
Functional Foods by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Dietary Supplements &
Functional Foods by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Pet & Animal Feed
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Pet & Animal Feed by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Pet & Animal Feed by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Infant Formula by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Infant Formula by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Infant Formula by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Pharmaceuticals
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Pharmaceuticals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Pharmaceuticals by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 19: USA Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 20: USA Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 21: USA 15-Year Perspective for Eicosapentaenoic Acid by
Application - Percentage Breakdown of Value Sales for Dietary
Supplements & Functional Foods, Pet & Animal Feed, Infant
Formula, Pharmaceuticals and Other Applications for the Years
2012, 2020 & 2027

CANADA
Table 22: Canada Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 23: Canada Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 24: Canada 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

JAPAN
Table 25: Japan Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 26: Japan Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 27: Japan 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

CHINA
Table 28: China Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 29: China Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 30: China 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

EUROPE
Table 31: Europe Current & Future Analysis for Eicosapentaenoic
Acid by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 32: Europe Historic Review for Eicosapentaenoic Acid by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 33: Europe 15-Year Perspective for Eicosapentaenoic Acid
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 34: Europe Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 35: Europe Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 36: Europe 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

FRANCE
Table 37: France Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 38: France Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 39: France 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

GERMANY
Table 40: Germany Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 41: Germany Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: Germany 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

ITALY
Table 43: Italy Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 44: Italy Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: Italy 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

UNITED KINGDOM
Table 46: UK Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 47: UK Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 48: UK 15-Year Perspective for Eicosapentaenoic Acid by
Application - Percentage Breakdown of Value Sales for Dietary
Supplements & Functional Foods, Pet & Animal Feed, Infant
Formula, Pharmaceuticals and Other Applications for the Years
2012, 2020 & 2027

SPAIN
Table 49: Spain Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Spain Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Spain 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

RUSSIA
Table 52: Russia Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Russia Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Russia 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

REST OF EUROPE
Table 55: Rest of Europe Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 56: Rest of Europe Historic Review for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 57: Rest of Europe 15-Year Perspective for
Eicosapentaenoic Acid by Application - Percentage Breakdown of
Value Sales for Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 58: Asia-Pacific Current & Future Analysis for
Eicosapentaenoic Acid by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 59: Asia-Pacific Historic Review for Eicosapentaenoic
Acid by Geographic Region - Australia, India, South Korea and
Rest of Asia-Pacific Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: Asia-Pacific 15-Year Perspective for Eicosapentaenoic
Acid by Geographic Region - Percentage Breakdown of Value Sales
for Australia, India, South Korea and Rest of Asia-Pacific
Markets for Years 2012, 2020 & 2027

Table 61: Asia-Pacific Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 62: Asia-Pacific Historic Review for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 63: Asia-Pacific 15-Year Perspective for Eicosapentaenoic
Acid by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

AUSTRALIA
Table 64: Australia Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 65: Australia Historic Review for Eicosapentaenoic Acid
by Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 66: Australia 15-Year Perspective for Eicosapentaenoic
Acid by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

INDIA
Table 67: India Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 68: India Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: India 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

SOUTH KOREA
Table 70: South Korea Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 71: South Korea Historic Review for Eicosapentaenoic Acid
by Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: South Korea 15-Year Perspective for Eicosapentaenoic
Acid by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

REST OF ASIA-PACIFIC
Table 73: Rest of Asia-Pacific Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 74: Rest of Asia-Pacific Historic Review for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 75: Rest of Asia-Pacific 15-Year Perspective for
Eicosapentaenoic Acid by Application - Percentage Breakdown of
Value Sales for Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications for the Years 2012, 2020 & 2027

LATIN AMERICA
Table 76: Latin America Current & Future Analysis for
Eicosapentaenoic Acid by Geographic Region - Argentina, Brazil,
Mexico and Rest of Latin America Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 77: Latin America Historic Review for Eicosapentaenoic
Acid by Geographic Region - Argentina, Brazil, Mexico and Rest
of Latin America Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 78: Latin America 15-Year Perspective for
Eicosapentaenoic Acid by Geographic Region - Percentage
Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest
of Latin America Markets for Years 2012, 2020 & 2027

Table 79: Latin America Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 80: Latin America Historic Review for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: Latin America 15-Year Perspective for
Eicosapentaenoic Acid by Application - Percentage Breakdown of
Value Sales for Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications for the Years 2012, 2020 & 2027

ARGENTINA
Table 82: Argentina Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 83: Argentina Historic Review for Eicosapentaenoic Acid
by Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: Argentina 15-Year Perspective for Eicosapentaenoic
Acid by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

BRAZIL
Table 85: Brazil Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 86: Brazil Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 87: Brazil 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

MEXICO
Table 88: Mexico Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 89: Mexico Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: Mexico 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

REST OF LATIN AMERICA
Table 91: Rest of Latin America Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 92: Rest of Latin America Historic Review for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 93: Rest of Latin America 15-Year Perspective for
Eicosapentaenoic Acid by Application - Percentage Breakdown of
Value Sales for Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications for the Years 2012, 2020 & 2027

MIDDLE EAST
Table 94: Middle East Current & Future Analysis for
Eicosapentaenoic Acid by Geographic Region - Iran, Israel,
Saudi Arabia, UAE and Rest of Middle East Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 95: Middle East Historic Review for Eicosapentaenoic Acid
by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest
of Middle East Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 96: Middle East 15-Year Perspective for Eicosapentaenoic
Acid by Geographic Region - Percentage Breakdown of Value Sales
for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East
Markets for Years 2012, 2020 & 2027

Table 97: Middle East Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 98: Middle East Historic Review for Eicosapentaenoic Acid
by Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 99: Middle East 15-Year Perspective for Eicosapentaenoic
Acid by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

IRAN
Table 100: Iran Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 101: Iran Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 102: Iran 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

ISRAEL
Table 103: Israel Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 104: Israel Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 105: Israel 15-Year Perspective for Eicosapentaenoic Acid
by Application - Percentage Breakdown of Value Sales for
Dietary Supplements & Functional Foods, Pet & Animal Feed,
Infant Formula, Pharmaceuticals and Other Applications for the
Years 2012, 2020 & 2027

SAUDI ARABIA
Table 106: Saudi Arabia Current & Future Analysis for
Eicosapentaenoic Acid by Application - Dietary Supplements &
Functional Foods, Pet & Animal Feed, Infant Formula,
Pharmaceuticals and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 107: Saudi Arabia Historic Review for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 108: Saudi Arabia 15-Year Perspective for
Eicosapentaenoic Acid by Application - Percentage Breakdown of
Value Sales for Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications for the Years 2012, 2020 & 2027

UNITED ARAB EMIRATES
Table 109: UAE Current & Future Analysis for Eicosapentaenoic
Acid by Application - Dietary Supplements & Functional Foods,
Pet & Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 110: UAE Historic Review for Eicosapentaenoic Acid by
Application - Dietary Supplements & Functional Foods, Pet &
Animal Feed, Infant Formula, Pharmaceuticals and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 111: UAE 15-Year Perspective for Eicosapentaenoic Acid by
Application - Percentage Breakdown of Value Sales for Dietary
Supplements & Functional Foods, Pet & Animal Feed, Infant
Formula, Pharmaceuticals and Other Applications for the Years
2012, 2020 & 2027

REST OF MIDDLE EAST

Please contact our Customer Support Center to get the complete Table of Contents